Eli Lilly and Company
11/13/2025 | Press release | Distributed by Public on 11/13/2025 13:12
Statement: Eli Lilly has no affiliation with Mangoceuticals, Inc.
Statement: Eli Lilly has no affiliation with Mangoceuticals, Inc.
Eli Lilly and Company (NYSE: LLY) has no affiliation with Mangoceuticals, Inc. Any communication or media report suggesting a partnership between Lilly and Mangoceuticals is false. In fact, Lilly sued Mangoceuticals last year and obtained a permanent injunction.
While Lilly has no affiliation or partnership with Mangoceuticals, any healthcare provider-including those who work with telehealth platforms-can prescribe Lilly medicines and send valid, on-label prescriptions for Zepbound (tirzepatide) single-dose vials directly to LillyDirect Self Pay Pharmacy Solutions for fulfillment.
# # #
Eli Lilly and Company published this content on November 13, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 13, 2025 at 19:12 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]